AI4Echolalia™ is currently undergoing Privacy & Safety Testing + Regulatory Assessment. This app is not open to the general public and is available only to approved users by DLYog Lab. Regulatory status (FDA/FTC) is uncertain.

Interested? Fill out this form to apply.

AI4Echolalia™
(Invite-Only Pilot)

Home-based echolalia detection system classifying immediate vs delayed repetition patterns with parent-directed coaching prompts.

Patent pending. Not a medical device.

Learn More

Aligned with UN Sustainable Development Goals

Goal 3: Good Health and Well-being
Goal 4: Quality Education
Goal 10: Reduced Inequalities

Featured in Georgia Tech News

TED AI 2024 Hackathon - 2nd Place Winner

"OMSCS Alum Teams with His Family to Create App Aiding Children with Echolalia" - Our innovative approach to supporting families affected by echolalia has been recognized by Georgia Tech and featured in their official news publication.

2nd Place - TED AI Hackathon 2024
Georgia Tech Recognition
Read the Full Story

Our Idea

Illustration showing AI-powered echolalia detection system for parent-child communication

Echolalia—repeating words or phrases—can carry meaning and emotion, yet it often makes daily communication harder for families. AI4Echolalia™ detects immediate vs delayed echolalia subtypes through turn-level transcript analysis with lexical repetition detection across timing windows. Parents receive coaching prompts based on classified echolalia patterns—between and alongside professional speech-language therapy.

Example: A familiar movie line ("Let it go") repeated immediately (within 2 seconds) or after delays is classified by semantic distance calculation. Our session-based pattern tracking helps parents recognize immediate vs delayed subtypes and receive echolalia-conditional prompts that invite more functional responses—at home, at school, and in the community.

Why now? Traditional clinical assessment lacks continuous home-context monitoring. AI4Echolalia™ enables hands-free echolalia detection during daily parent-child sessions with repetition-reduction metrics—complementing (not replacing) speech-language therapy.

Features

Real-time immediate and delayed echolalia classification with timing windows and semantic distance calculation

Immediate & Delayed Echolalia Classification

Turn-level transcript analysis with timing windows detects lexical repetition patterns. Immediate (within 2 seconds) vs delayed echolalia classified through semantic distance calculation—so parents can receive subtype-specific coaching prompts.

Parent receiving echolalia-conditional coaching prompts based on detected immediate versus delayed repetition patterns

Echolalia-Conditional Parent Prompts

Based on detected immediate vs delayed echolalia subtypes, parents receive coaching prompts specific to classified repetition patterns. Guidance is for home-based parent learning, not clinical treatment.

Dashboard showing session-based repetition reduction metrics and echolalia frequency trends over time

Session-Based Repetition Reduction Metrics

We store non-identifying session summaries tracking immediate vs delayed echolalia frequency over time (not audio). View repetition-reduction trends and functional language increases across home-based parent-child sessions.

About AI4Echolalia™

A home-based echolalia detection system for parents. Classifies immediate vs delayed echolalia subtypes through turn-level transcript analysis with timing windows and semantic distance scoring. Patent pending (U.S. non-provisional). Recognition: TED AI San Francisco Hackathon — 2nd Place (event reference only; no endorsement implied).

Get in Touch
AI4Echolalia turn-level transcript analysis system with parent coaching interface

How We Handle Data

✓ No Audio Storage

Parent-child sessions are transcribed for turn-level echolalia analysis, then deleted. Audio is never stored on our servers.

✓ Anonymized Text Only

We send de-identified transcripts for lexical repetition detection and echolalia subtype classification through semantic distance calculation.

✓ Minimal Retention

We keep session-based echolalia frequency counts (immediate vs delayed) and repetition-reduction metrics to help track patterns over time.

✓ You Control

You can export or delete your session data upon request. Parents control all inputs and session recordings.

Regulatory Transparency & User Awareness

Important: Regulatory Uncertainty

We are actively assessing whether AI4Echolalia™ may fall under FDA or FTC regulations. While we position our app as educational-only, the regulatory landscape for mobile health applications is evolving, and we want to be completely transparent with potential users.

We are currently reviewing our app against FDA and FTC guidelines to determine if regulatory compliance may be required. If you are not comfortable with this regulatory uncertainty, please do not apply for access.

FTC Mobile Health Apps

The FTC provides guidance for apps that access, collect, or maintain health-related information, including fitness, wellness, mood tracking, and health monitoring applications.

→ View FTC Mobile Health Apps Tool

FDA Device Software Functions

The FDA regulates software functions that meet the definition of a medical device, including mobile medical applications that diagnose, treat, or affect health conditions.

→ View FDA Device Software Guidance

Our Commitment to Transparency

  • We are actively reviewing our app against relevant regulatory frameworks
  • We will comply with any applicable regulations as determinations are made
  • We maintain our educational-only positioning while assessing regulatory requirements
  • Users will be notified of any regulatory status changes or compliance updates

User Decision: By applying for access, you acknowledge this regulatory uncertainty and choose to participate in our pilot knowing that regulatory status may change. If you prefer to wait until regulatory clarity is achieved, please do not apply at this time.

Get in Touch

Have questions or want to learn more? Contact us today.

Contact Us
For Investors & Strategic Partners

Intellectual Property & Patent Protection

US Patent Application Filed

We have filed a US non-provisional patent application covering our core technology and innovations in echolalia detection and analysis.

Freedom to Operate (FTO) Analysis

We have completed a comprehensive Freedom to Operate (FTO) analysis to ensure our technology does not infringe on existing patents.

Status: ZERO INFRINGEMENT RISK

Ongoing Due Diligence: Working document, continuously updated

Our FTO analysis is a living document that reflects our commitment to respecting intellectual property rights.

Access to Detailed Documentation

For investors, strategic partners, and stakeholders interested in reviewing our detailed patent application and FTO analysis:

Upon execution of a Non-Disclosure Agreement (NDA), we can provide:

  • Complete FTO analysis report
  • Patent application details
  • IP strategy roadmap
Request Access via NDA

Contact: legal@dlyog.com

Our Commitment: We prioritize transparency, respect for intellectual property rights, and rigorous due diligence in all our innovations.